Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma

Zsfassung in dt. Sprache

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hering, Esther 1979- (VerfasserIn)
Format: Abschlussarbeit Buch
Sprache:English
German
Veröffentlicht: 2012
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 c 4500
001 BV040755401
003 DE-604
005 00000000000000.0
007 t|
008 130218s2012 xx ad|| m||| 00||| eng d
035 |a (OCoLC)828804725 
035 |a (DE-599)HBZHT017509647 
040 |a DE-604  |b ger 
041 0 |a eng  |a ger 
049 |a DE-355 
084 |a 610  |2 sdnb 
100 1 |a Hering, Esther  |d 1979-  |e Verfasser  |0 (DE-588)1029739595  |4 aut 
245 1 0 |a Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma  |c vorgelegt von Hering, Esther 
264 1 |c 2012 
300 |a 48 Bl.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
502 |a Münster (Westfalen), Univ., Diss., 2012 
520 8 |a Zsfassung in dt. Sprache 
655 7 |0 (DE-588)4113937-9  |a Hochschulschrift  |2 gnd-content 
943 1 |a oai:aleph.bib-bvb.de:BVB01-025735081 

Datensatz im Suchindex

_version_ 1819289510758842368
any_adam_object
author Hering, Esther 1979-
author_GND (DE-588)1029739595
author_facet Hering, Esther 1979-
author_role aut
author_sort Hering, Esther 1979-
author_variant e h eh
building Verbundindex
bvnumber BV040755401
ctrlnum (OCoLC)828804725
(DE-599)HBZHT017509647
discipline Medizin
format Thesis
Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00962nam a2200289 c 4500</leader><controlfield tag="001">BV040755401</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">130218s2012 xx ad|| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)828804725</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT017509647</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hering, Esther</subfield><subfield code="d">1979-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1029739595</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma</subfield><subfield code="c">vorgelegt von Hering, Esther</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">48 Bl.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Münster (Westfalen), Univ., Diss., 2012</subfield></datafield><datafield tag="520" ind1="8" ind2=" "><subfield code="a">Zsfassung in dt. Sprache</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025735081</subfield></datafield></record></collection>
genre (DE-588)4113937-9 Hochschulschrift gnd-content
genre_facet Hochschulschrift
id DE-604.BV040755401
illustrated Illustrated
indexdate 2024-12-24T03:08:00Z
institution BVB
language English
German
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-025735081
oclc_num 828804725
open_access_boolean
owner DE-355
DE-BY-UBR
owner_facet DE-355
DE-BY-UBR
physical 48 Bl. Ill., graph. Darst.
publishDate 2012
publishDateSearch 2012
publishDateSort 2012
record_format marc
spelling Hering, Esther 1979- Verfasser (DE-588)1029739595 aut
Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma vorgelegt von Hering, Esther
2012
48 Bl. Ill., graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Münster (Westfalen), Univ., Diss., 2012
Zsfassung in dt. Sprache
(DE-588)4113937-9 Hochschulschrift gnd-content
spellingShingle Hering, Esther 1979-
Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma
subject_GND (DE-588)4113937-9
title Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma
title_auth Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma
title_exact_search Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma
title_full Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma vorgelegt von Hering, Esther
title_fullStr Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma vorgelegt von Hering, Esther
title_full_unstemmed Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma vorgelegt von Hering, Esther
title_short Expression of somatostatin receptor subtype 2 (sst 2 ) is a prognostic marker and therapeutic target in high risk medulloblastoma
title_sort expression of somatostatin receptor subtype 2 sst 2 is a prognostic marker and therapeutic target in high risk medulloblastoma
topic_facet Hochschulschrift
work_keys_str_mv AT heringesther expressionofsomatostatinreceptorsubtype2sst2isaprognosticmarkerandtherapeutictargetinhighriskmedulloblastoma